PAR-25-338-Full-Announcement.html

This HTML document contains a Notice of Funding Opportunity (NOFO) PAR-25-338 from the National Cancer Institute (NCI) and National Institutes of Health (NIH) for Academic-Industrial Partnerships focused on translating technologies for disease diagnosis and treatment. The opportunity is structured as an R01 grant that does not allow clinical trials.

The funding aims to support translation of scientific discoveries and engineering developments into practical methods and tools for disease research, risk assessment, detection, prevention, diagnosis, and treatment. It falls under multiple CFDA programs including Cancer Detection and Diagnosis Research (93.394), Cancer Treatment Research (93.395), Vision Research (93.867), Oral Diseases Research (93.121), and NIH Office of Research on Women's Health (93.313). Eligible applicants include higher education institutions, nonprofits, small businesses, tribal organizations, and various government entities. The grant focuses on developing new capabilities for both pre-clinical and clinical settings, though specific award amounts and dates are not provided in this excerpt.